This hottest twist in the Lykos Therapeutics saga threatens A significant overhaul of the company’s method and route, with Musk ally and billionaire investor Antonio Gracias showing to choose to acquire the corporate back toward its nonprofit drug development roots and a more Doblinite philosophy., James writes about why so Lots of individuals �